Does ENCORAFENIB Cause Red cell distribution width increased? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Red cell distribution width increased have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.1% of all adverse event reports for ENCORAFENIB.
6
Reports of Red cell distribution width increased with ENCORAFENIB
0.1%
of all ENCORAFENIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Red cell distribution width increased From ENCORAFENIB?
Of the 6 reports, 1 (16.7%) resulted in death, 1 (16.7%) required hospitalization.
Is Red cell distribution width increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENCORAFENIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Red cell distribution width increased?
CLOZAPINE (439)
METHOTREXATE (210)
ALEMTUZUMAB (202)
RITUXIMAB (198)
PREDNISONE (178)
PALBOCICLIB (171)
ADALIMUMAB (144)
METHYLPREDNISOLONE (123)
ECULIZUMAB (110)
TOCILIZUMAB (108)
Which ENCORAFENIB Alternatives Have Lower Red cell distribution width increased Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN